152 related articles for article (PubMed ID: 8390353)
1. Receptor mechanisms and dose-response models for the effects of dioxins.
Lucier GW; Portier CJ; Gallo MA
Environ Health Perspect; 1993 Apr; 101(1):36-44. PubMed ID: 8390353
[TBL] [Abstract][Full Text] [Related]
2. Integrated approach for evaluating species and interindividual differences in responsiveness to dioxins and structural analogs.
Clark G; Tritscher A; Bell D; Lucier G
Environ Health Perspect; 1992 Nov; 98():125-32. PubMed ID: 1336723
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of dioxin toxicity: relationship to risk assessment.
Birnbaum LS
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):157-67. PubMed ID: 7698077
[TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) as a potent and persistent thyroxine agonist: a mechanistic model for toxicity based on molecular reactivity.
McKinney JD; Fawkes J; Jordan S; Chae K; Oatley S; Coleman RE; Briner W
Environ Health Perspect; 1985 Sep; 61():41-53. PubMed ID: 2998749
[TBL] [Abstract][Full Text] [Related]
5. Persistent, low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effect on aryl hydrocarbon receptor expression in a dioxin-resistance model.
Franc MA; Pohjanvirta R; Tuomisto J; Okey AB
Toxicol Appl Pharmacol; 2001 Aug; 175(1):43-53. PubMed ID: 11509025
[TBL] [Abstract][Full Text] [Related]
6. Dioxins and the Ah receptor.
Silbergeld EK; Gasiewicz TA
Am J Ind Med; 1989; 16(4):455-74. PubMed ID: 2558567
[TBL] [Abstract][Full Text] [Related]
7. Carcinogenic risks of dioxin: mechanistic considerations.
Schwarz M; Appel KE
Regul Toxicol Pharmacol; 2005 Oct; 43(1):19-34. PubMed ID: 16054739
[TBL] [Abstract][Full Text] [Related]
8. Science policy choices and the estimation of cancer risk associated with exposure to TCDD.
Gough M
Risk Anal; 1988 Sep; 8(3):337-42. PubMed ID: 2849149
[TBL] [Abstract][Full Text] [Related]
9. Ah receptor mediating induction of aryl hydrocarbon hydroxylase: detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin.
Roberts EA; Golas CL; Okey AB
Cancer Res; 1986 Jul; 46(7):3739-43. PubMed ID: 3011254
[TBL] [Abstract][Full Text] [Related]
10. Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment.
Andersen ME; Mills JJ; Gargas ML; Kedderis L; Birnbaum LS; Neubert D; Greenlee WF
Risk Anal; 1993 Feb; 13(1):25-36. PubMed ID: 8383868
[TBL] [Abstract][Full Text] [Related]
11. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions.
Bock KW; Köhle C
Biochem Pharmacol; 2006 Aug; 72(4):393-404. PubMed ID: 16545780
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
Poland A; Teitelbaum P; Glover E; Kende A
Mol Pharmacol; 1989 Jul; 36(1):121-7. PubMed ID: 2546046
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line.
Harper PA; Golas CL; Okey AB
Cancer Res; 1988 May; 48(9):2388-95. PubMed ID: 2833345
[TBL] [Abstract][Full Text] [Related]
14. Is the fear of dioxin cancer more harmful than dioxin?
Tuomisto J; Tuomisto JT
Toxicol Lett; 2012 May; 210(3):338-44. PubMed ID: 22387160
[TBL] [Abstract][Full Text] [Related]
15. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
Harris M; Zacharewski T; Astroff B; Safe S
Mol Pharmacol; 1989 May; 35(5):729-35. PubMed ID: 2542761
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
17. [Impacts and impact mechanisms of "dioxins" in humans and animals].
Nau H
Dtsch Tierarztl Wochenschr; 2006 Aug; 113(8):292-7. PubMed ID: 16955640
[TBL] [Abstract][Full Text] [Related]
18. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
19. Ah receptor: relevance of mechanistic studies to human risk assessment.
Cook JC; Gaido KW; Greenlee WF
Environ Health Perspect; 1987 Dec; 76():71-7. PubMed ID: 2834195
[TBL] [Abstract][Full Text] [Related]
20. Dioxin and cancer: a critical review.
Cole P; Trichopoulos D; Pastides H; Starr T; Mandel JS
Regul Toxicol Pharmacol; 2003 Dec; 38(3):378-88. PubMed ID: 14623487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
